Intellia: Molecular Machetes In The Dark
Cassandra smells the ash before the fire is lit. In this chilling audit, we plunge into the precarious world of Intellia Therapeutics, a biotech titan promising to rewrite the human source code with CRISPR. But is their "precision-engineered enzymatic cleavage" a miracle cure or a "molecular machete in the dark"? Marcus, ever the cynical humanist, sees a "biological minefield" where "off-target edits" and unforeseen consequences loom large. Katie, the unflappable clinician, counters with data, regulatory frameworks, and the immutable logic of the market. Their tense dialogue exposes the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.